Proteomics Studies of Stem Cells

Dear Colleagues,

The 21st century is undoubtedly the time of the most intensive research on the topic of stem cells. Stem cells are commonly used in animal model studies (e.g., mouse, rat, rabbit, as well as dog, pig or goat), both those in the field of basic research and aiming to design new forms of targeted therapy. The basic animal model studies focus on the analysis of physiological and biochemical properties of stem cells, while clinical research searches for the best way of cell-based therapy administration, as well as their interaction with drugs and other cells and tissues of the organism. In vitro research continues to play an important role in the medicine, as preclinical and clinical trials are still associated with a high risk of post-treatment complications. Nevertheless, stem cell therapies are increasingly common in orthopedics and traumatology, plastic surgery, aesthetic medicine, and cosmetology.

Additionally, there have been some far more advanced studies on the biotechnology of stem cells in bird, fish (Danio rerio), or Caenorhabditis elegans embryos, as well as plants.

Despite increasing knowledge on the physiological properties of stem cells, a large number of genetic, molecular, and biochemical studies still needs to be conducted. The development of transcriptomic and proteomic techniques allows for complex discovery of stem cell properties. Proteomic analyses, from the simple Western blot to advanced methods of mass spectrometry, permit the discovery and detailed molecular identification of new protein markers, the structure and biochemical activity of which is key from the viewpoint of therapeutic properties of stem cells.

This Special Issue aims to present the results of studies concerning proteomic analyses in the field of human, animal and plant stem cell bioengineering.  

Dr. Bartosz Kempisty
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Proteomes is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.